UlysseRe Limited

Date authorised
1 April 2013
Companies House
03606440
Last scraped
2 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    Office Suite 2.15
    34 Lime Street
    London
    EC3M 7AT
    UNITED KINGDOM
    Phone
    +442033970951
    Web
    https://ulyssere.uk

  • Complaints Contact

    Office Suite 2.15
    34 Lime Street
    London
    EC3M 7AT
    UNITED KINGDOM
    Phone
    +442033970951

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Investment Advice (no pensions)

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.

  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Insurance Admin

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Stockbroking

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Andrew Jonathan Clowes

    IRN AJC01614

    • CF1 Director (AR) (since 23 Jan 2023)
  • Brian Wright

    IRN BXW01228

    • SMF3 Executive Director (9 Dec 2019 to 16 Sep 2020)
    • Responsible for Insurance Distribution (1 Oct 2018 to 16 Sep 2020)
    • CF1 Director (AR) (16 Jul 2010 to 16 Sep 2020)
    • CF28 Systems and controls (1 Nov 2007 to 22 Nov 2016)
    • CF29 Significant management (1 Nov 2007 to 22 Nov 2016)
    • CF15 Internal Audit (14 Jan 2005 to 31 Oct 2007)
    • CF14 Risk Assessment (14 Jan 2005 to 31 Oct 2007)
    • CF13 Finance (14 Jan 2005 to 31 Oct 2007)
    • CF11 Money Laundering Reporting (14 Jan 2005 to 22 Nov 2016)
    • CF1 Director (14 Jan 2005 to 8 Dec 2019)
    • CF8 Apportionment and Oversight (14 Jan 2005 to 31 Mar 2009)
    • Responsible for Insurance Mediation (14 Jan 2005 to 30 Sep 2018)
    • CF19 Significant Mgt (Financial Resources) (14 Jan 2005 to 31 Oct 2007)
    • CF17 Significant Mgt (Other Business Operations) (14 Jan 2005 to 31 Oct 2007)
  • Christopher Arthur Hugh Barker

    IRN CAB01298

    • Responsible for Insurance Distribution (since 1 Sep 2020)
    • SMF3 Executive Director (since 1 Sep 2020)
  • Daniel Anthony Cowen

    IRN DXC00641

    • CF1 Director (AR) (since 22 Mar 2023)
  • Helen Dorothy Barker

    IRN HXB46850

    • CF1 Director (AR) (since 2 Mar 2026)
    • SMF3 Executive Director (since 10 Jun 2020)
  • Hugo Charles Merison

    IRN HCM01037

    • SMF3 Executive Director (17 Oct 2024 to 21 Oct 2025)
  • Kevin Kettrick

    IRN KXK01274

    • CF4 Partner (AR) (since 6 Mar 2025)
  • Matthew Tyler

    IRN MXT00731

    • CF1 Director (AR) (since 15 Sep 2025)
  • Philip Lundberg

    IRN PXL00141

    • CF1 Director (AR) (29 Jul 2022 to 30 Nov 2023)

Appointed representatives

Smaller firms operating under this firm's FCA authorisation.

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.